The inhaled monoclonal antibody IN-006 shows promise in COVID-19 treatment, with high airway antibody levels and a favorable safety profile in healthy adults.
Craft ( Miami Opa-Locka) has ceased Gulfstream Aerospace commercial operations following the retirement of the last GIV-SP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback